David R.W. Jayne insider trades
Open-market stock purchases and sales by David R.W. Jayne, Director at Aurinia Pharmaceuticals Inc, from SEC Form 4 filings since Jun 14, 2021.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- AUPH Aurinia Pharmaceuticals Inc: 2 sales, last Nov 21, 2024